IP Library › Granted Patent US 12,213,482
Granted Patent B2
US 12,213,482 · App. 17/407,959 · Granted Feb 4, 2025

Fungicide enhancers effective for treating plants infected with fungal pathogens

Inventors: Stanley J. Roux (Austin, TX); Gregory B. Clark (Austin, TX); Simon L. Hiebert (Austin, TX)
Assignees: Board of Regents, The University of Texas System; Cottongen, LLC
A01N41/02A01N37/02A01N37/26A01N41/06A01N43/16A01N43/653A01N59/20C12N5/04A01N2300/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,213,482
App. No.
17/407,959
Granted
Feb 4, 2025
Kind
B2
Abstract

The present invention includes compositions and methods of for treating plants infected with fungal pathogens by contacting an infected plant or plant at risk of infection with a fungicidal composition comprising an fungicide selected from copper compound such as copper octanoate or copper hydroxide, or a triazole fungicide such as myclobutanil, propionazole, tebuconazole or epoxiconazole, an enhancer selected from apyrase inhibitors, e.g., N-(m-tolyl)-[1,1′-biphenyl]-4-sulfonamide, S-heptyl 2-oxo-2H-chromene 3-carbothioate, 3-(N-(4-bromophenyl) sulfamoyl)-N-(3-nitrophenyl)benzamide, or (E)-3-methyl-N-(1-(naphthalen-2-yl) ethylidene)benzohydrazide and, optionally, a phytologically-acceptable inert carrier.

Claims (25)

1. A composition comprising a fungicide comprising:

a) copper octanoate, and an enhancer selected from N-(m-tolyl)-[1,1′-biphenyl]-4-sulfonamide, S-heptyl 2-oxo-2H-chromene-3-carbothioate, 3-(N-(4-bromophenyl) sulfamoyl)-N-(3-nitrophenyl)benzamide, or (E)-3-methyl-N′-(1-(naphthalen-2-yl)ethylidene);

b) myclobutanil and an enhancer selected from N-(m-tolyl)-[1,1′-biphenyl]-4-sulfonamide, S-heptyl 2-oxo-2H-chromene-3-carbothioate, 3-(N-(4-bromophenyl) sulfamoyl)-N-(3-nitrophenyl)benzamide, or (E)-3-methyl-N′-(1-(naphthalen-2-yl)ethylidene) benzohydrazide;

c) propiconazole and an enhancer selected from N-(m-tolyl)-[1,1′-biphenyl]-4-sulfonamide or 3-(N-(4-bromophenyl) sulfamoyl)-N-(3-nitrophenyl)benzamide;

d) tebuconazole and an enhancer selected from N-(m-tolyl)-[1,1′-biphenyl]-4-sulfonamide, S-heptyl 2-oxo-2H-chromene-3-carbothioate or 3-(N-(4-bromophenyl) sulfamoyl)-N-(3-nitrophenyl)benzamide

e) copper hydroxide and (E)-3-methyl-N′-(1-(naphthalen-2-yl)ethylidene) benzohydrazide;

f) prothioconazole and (E)-3-methyl-N′-(1-(naphthalen-2-yl)ethylidene) benzohydrazide; or

g) difenoconazole and (E)-3-methyl-N′-(1-(naphthalen-2-yl)ethylidene) benzohydrazide.

2. The composition of claim 1 , wherein the composition further comprises a phytologically-acceptable inert carrier.

3. The composition of claim 1 , wherein the amount of the fungicide is not effective for treating a fungus.

4. The composition of claim 1 , wherein the amount of the fungicide is effective for treating a fungus and is adapted for application to a fungicide-resistant fungus.

5. The composition of claim 1 , wherein the enhancer is provided at 0.005, 0.01, 0.05, 0.1, 0.5, 1.0, 1.1, 1.2, 1.3, 1.4, 1.5, 1.6, 1.7, 1.8, 1.9, 2.0, 2.5, 3.0, 4.0, 5.0, 7.5, or 10% weight to weight enhancer to fungicide.

6. The composition of claim 1 , wherein the enhancer is provided at 0.005, 0.01, 0.05, 0.1, 0.5, 1.0, 1.1, 1.2, 1.3, 1.4, 1.5, 1.6, 1.7, 1.8, 1.9, 2.0, 2.5, 3.0, 4.0, 5.0, 7.5, or 10% volume to volume enhancer to fungicide.

7. The composition of claim 1 , wherein the composition is synergistic and the weight ratio of the fungicide to the enhancer is between about 500:1 and 5000:1.

8. A fungicide comprising:

a) copper octanoate; and an apyrase inhibitor selected from N-(m-tolyl)-[1,1′-biphenyl]-4-sulfonamide, S-heptyl 2-oxo-2H-chromene-3-carbothioate, 3-(N-(4-bromophenyl) sulfamoyl)-N-(3-nitrophenyl)benzamide, or (E)-3-methyl-N′-(1-(naphthalen-2-yl)ethylidene);

b) myclobutanil and an enhancer selected from N-(m-tolyl)-[1,1′-biphenyl]-4-sulfonamide, S-heptyl 2-oxo-2H-chromene-3-carbothioate, 3-(N-(4-bromophenyl) sulfamoyl)-N-(3-nitrophenyl)benzamide, or (E)-3-methyl-N′-(1-(naphthalen-2-yl)ethylidene) benzohydrazide;

c) propiconazole and an enhancer selected from N-(m-tolyl)-[1,1′-biphenyl]-4-sulfonamide or 3-(N-(4-bromophenyl) sulfamoyl)-N-(3-nitrophenyl)benzamide;

d) tebuconazole and an enhancer selected from N-(m-tolyl)-[1,1′-biphenyl]-4-sulfonamide, S-heptyl 2-oxo-2H-chromene-3-carbothioate or 3-(N-(4-bromophenyl) sulfamoyl)-N-(3-nitrophenyl)benzamide

e) copper hydroxide and (E)-3-methyl-N′-(1-(naphthalen-2-yl)ethylidene) benzohydrazide;

f) prothioconazole and (E)-3-methyl-N′-(1-(naphthalen-2-yl)ethylidene) benzohydrazide; or

g) difenoconazole and (E)-3-methyl-N′-(1-(naphthalen-2-yl)ethylidene) benzohydrazide, in amounts sufficient to treat a fungus.

9. The fungicide of claim 8 , wherein the fungicide is added to a growth media for growing cells.

10. The fungicide of claim 8 , wherein the cells are selected from at least one of bacterial, fungal, plant, animal, mammalian, yeast, amphibian, avian, nematode or insect cells.

11. The fungicide of claim 8 , wherein the composition is synergistic and the weight ratio of the fungicide to the apyrase inhibitor is between about 500:1 and 5000:1.

Continuity (3)
Division 15547008
Provisional Application 62108114 · Jan 27, 2015
Related Publication 20220039381A1 · Feb 10, 2022
References Cited (26)
US 6448472B1 · Thomas et al. · 2002 [cited by applicant]
US 11129383B2 · Roux · 2021 [cited by examiner]
US 20020077365A1 · Windsor et al. · 2002 [cited by applicant]
US 20020103082A1 · Windsor et al. · 2002 [cited by applicant]
US 20020173031A1 · Thomas et al. · 2002 [cited by applicant]
US 20030008369A1 · Windsor et al. · 2003 [cited by applicant]
US 20060027633A1 · Miyake · 2006 [cited by applicant]
US 20060276339A1 · Windsor et al. · 2006 [cited by applicant]
US 20100305161A1 · Bosselaers et al. · 2010 [cited by applicant]
JP 2002529378A · 2002 [cited by applicant]
JP 2003531154A · 2003 [cited by applicant]
JP 2007522187A · 2007 [cited by applicant]
WO 0166792A1 · 2001 [cited by applicant]
WO 0220726A2 · 2002 [cited by applicant]
WO 2005014777A2 · 2005 [cited by applicant]
WO 2012167023 · 2012 [cited by applicant]
WO 2013071824B1 · 2013 [cited by applicant]
International Search Report and Written Opinion for PCT/US2016/015077 dated Apr. 21, 2016. [cited by applicant]
Windsor et al., “Automated colorimetric screen for apyrase inhibitors,” Biotechniques, 33(5):1028-1030, 2002. [cited by applicant]
Windsor et al., “Multiherbicide tolerance conferred by AtPgp1 and apyrase overexpression in [cited by applicant]
Extended European Search Report regarding European Application No. 16744015, dated Jun. 4, 2018. [cited by applicant]
Coleman et al., “Efflux in Fungi: La Piece de Resistance,” PLOS Pathogens 5(6):1-7, 2009. [cited by applicant]
Reimann et al., “Inhibition of Efflux Transporter-Mediated Fungicide Resistance in Pyrenophora tritici-repentis by a Derivative of 4′-Hydroxyflavone and Enhancement of Fungicide Activity,” Applied and Environmental Micr… [cited by applicant]
Tripathy et al., “Apyrase inhibitors enhance the ability of diverse fungicides to inhibit the growth of different plant-pathogenic fungi,” Molecular Plant Pathology 18(7):1012-1023, 2017. [cited by applicant]
Kumar et al. “Apyrase inhibitors enhance the ability of diverse fungicides to inhibit the growth of different plant-pathogenic fungi,” Mol. Plant Pathol. Sep. 2017;18(7):1012-23, PMID: 27392542. (Year: 2017). [cited by applicant]
Indonesian Office Action regarding Indonesian App. No. P00201705655, May 28, 2024. [cited by applicant]